Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Flow Traders unveils Horizon 2030 strategy to become top 24/7 liquidity provider with €1B+ net trading income target.

Market News
23 Jun 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

Flow Traders announced its Horizon 2030 strategy aiming to become the preferred 24/7 liquidity provider by leveraging AI, technology, and expanding across traditional, digital, and tokenized assets. The company set ambitious financial goals for 2030, including net trading income exceeding €1 billion, a return on trading capital above 50%, and an EBITDA margin over 45%. The strategy focuses on six pillars: research and technology, product expansion, connectivity, distribution, trading and execution, and risk and capital management. Flow Traders plans to grow its ETF business, digital assets, and tokenized markets while enhancing its technology and distribution to capture emerging market opportunities. The company expects transitional years through 2026 and early 2027 before investment benefits boost trading income from mid-2027 onwards.

More News

EU approves Cenrifki as first drug targeting disability progression in secondary progressive multiple sclerosis without relapses

EU approves Cenrifki as first drug targeting disability progression in secondary progressive multiple sclerosis without relapses

The European Commission has approved Cenrifki (tolebrutinib) by Sanofi for treating secondary progressive multiple sclerosis (SPMS) without relapses, based on positive phase 3 trial results showing it delays disability progression. This is the first ...

Market News
Bullish
51 minutes ago
argenx hosts webinar on advancing FcRn leadership in autoimmune myositis R&D

argenx hosts webinar on advancing FcRn leadership in autoimmune myositis R&D

argenx, a global immunology company, is hosting a webinar on June 23, 2026, focused on advancing research and development of FcRn blockers for autoimmune myositis. The event features argenx's management and scientific leaders alongside key external e...

Others
Bullish
51 minutes ago
Signify unveils strategy to boost focus, performance, and shareholder value by 2029.

Signify unveils strategy to boost focus, performance, and shareholder value by 2029.

Signify announced a new strategy at its 2026 Capital Markets Day to become a more focused and better-performing company by 2029. The plan includes prioritizing growth in connected lighting and consumer segments while optimizing less profitable areas....

Market News
Bullish
51 minutes ago
EU approves Sanofi's Cenrifki for secondary progressive multiple sclerosis without relapses

EU approves Sanofi's Cenrifki for secondary progressive multiple sclerosis without relapses

The European Commission has approved Sanofi's Cenrifki (tolebrutinib) as the first medicine targeting disability progression in secondary progressive multiple sclerosis (SPMS) without relapses. Approval is based on positive phase 3 clinical trial res...

Market News
Bullish
51 minutes ago
CTO confidence in scaling AI drops to 48% despite rising investments, highlighting integration challenges.

CTO confidence in scaling AI drops to 48% despite rising investments, highlighting integration challenges.

Akkodis' 2026 study reveals CTO confidence in scaling AI has fallen from 82% in 2024 to 48% in 2026, despite rapid AI adoption and increased investments. The main challenge is not technology but integrating AI into company systems, processes, and dec...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App